AU5672000A - Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof - Google Patents
Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereofInfo
- Publication number
- AU5672000A AU5672000A AU56720/00A AU5672000A AU5672000A AU 5672000 A AU5672000 A AU 5672000A AU 56720/00 A AU56720/00 A AU 56720/00A AU 5672000 A AU5672000 A AU 5672000A AU 5672000 A AU5672000 A AU 5672000A
- Authority
- AU
- Australia
- Prior art keywords
- therapy
- selecting
- detecting
- effect
- effective therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19922052A DE19922052A1 (en) | 1999-05-14 | 1999-05-14 | Determining the effect of chemotherapy and/or radiotherapy on malignancies comprises determining the expression profiles of or mutations in genes that regulate apoptosis and/or cell growth |
| DE19922052 | 1999-05-14 | ||
| PCT/DE2000/001444 WO2000070085A2 (en) | 1999-05-14 | 2000-05-10 | Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5672000A true AU5672000A (en) | 2000-12-05 |
Family
ID=7907938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU56720/00A Abandoned AU5672000A (en) | 1999-05-14 | 2000-05-10 | Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1181394A2 (en) |
| AU (1) | AU5672000A (en) |
| DE (1) | DE19922052A1 (en) |
| WO (1) | WO2000070085A2 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2163650T3 (en) | 2004-04-09 | 2015-11-02 | Genomic Health Inc | Genekspressionsmarkører for prediction of response to chemotherapy |
| US8624027B2 (en) | 2005-05-12 | 2014-01-07 | Abbvie Inc. | Combination therapy for treating cancer and diagnostic assays for use therein |
| US8768629B2 (en) | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| JP2009537154A (en) | 2006-05-18 | 2009-10-29 | モレキュラー プロファイリング インスティテュート， インコーポレイテッド | System and method for determining personalized medical intervention for disease states |
| EP2474625B1 (en) * | 2011-01-05 | 2016-11-02 | Daniela Kandioler | Method for determining the p53 status of a tumour |
| EP2474624B1 (en) | 2011-01-05 | 2016-08-17 | Daniela Kandioler | Response prediction in cancer treatment (p53 adapted cancer therapy) |
| WO2022216725A1 (en) * | 2021-04-05 | 2022-10-13 | Brown University | Methods for optimizing the treatment of colorectal cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0988398A4 (en) * | 1997-05-21 | 2005-05-18 | Clontech Lab Inc | Nucleic acid arrays |
-
1999
- 1999-05-14 DE DE19922052A patent/DE19922052A1/en not_active Withdrawn
-
2000
- 2000-05-10 AU AU56720/00A patent/AU5672000A/en not_active Abandoned
- 2000-05-10 WO PCT/DE2000/001444 patent/WO2000070085A2/en not_active Application Discontinuation
- 2000-05-10 EP EP00941910A patent/EP1181394A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1181394A2 (en) | 2002-02-27 |
| WO2000070085A3 (en) | 2001-08-09 |
| DE19922052A1 (en) | 2000-11-16 |
| WO2000070085A2 (en) | 2000-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| HUP0201757A2 (en) | Compositoins and methods for the therapy and diagnosis of lung cancer | |
| HUS1500001I1 (en) | Use of et743 in combination therapy with dexamethasone for treating cancer | |
| HUP0200760A2 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2003200740A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2003200722A1 (en) | Compositions and methods for the treatment of tumor | |
| AU2495200A (en) | Compositions and methods for the treatment of tumor | |
| AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
| HUP0001316A3 (en) | Method for the detection and localization of malignant human tumours | |
| KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
| PL373912A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
| IL211081A0 (en) | Methods and devices for providing prolonged drug therapy | |
| IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
| AUPQ201499A0 (en) | Treatment of inflammatory and malignant diseases | |
| AU5672000A (en) | Method for detecting the effect of different chemotherapeutic agents and/or radiation therapy in malignant diseases and method for selecting more effective therapeutic agents for the therapy thereof | |
| AU6111800A (en) | 26 human prostate and prostate cancer associated proteins | |
| IL132531A0 (en) | Detection and therapy of tumors | |
| AU5946999A (en) | Tumour therapy and imaging | |
| AU4452900A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2351699A (en) | The human calcium-sensing receptor in the detection and treatment of cancer | |
| PL352681A1 (en) | Preventive and therapeutic agents for cancer | |
| GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
| EP1001966A4 (en) | A senescence gene and its use in the treatment of cancer and other diseases | |
| AU6404698A (en) | Treatment methods for obtaining therapeutic products and resulting products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |